Overview of Share Repurchase Program
dsm-firmenich, a leader in nutrition, health, and beauty innovation, recently embarked on an ambitious share repurchase program aimed at enhancing shareholder value. This initiative commenced with a plan to repurchase ordinary shares worth €1 billion, with the first tranche set at €500 million.
Details of the Implementation
The repurchase program officially kicked off on April 1 with an allocation of €580 million. This budget is divided into two significant components: €80 million dedicated to meeting commitments under share-based compensation plans and €500 million aimed at reducing issued capital. This strategic approach not only increases investor confidence but also aligns the company's financial strategies with shareholder interests.
Recent Transactions
As of June 20, 2025, dsm-firmenich reported a total repurchase of 454,824 shares over the previous week, paying an average price of €95.25 per share for a total outlay of €43.3 million. In total, since the inception of the program, 3,164,700 shares have been repurchased at an average price of €94.84, totaling €300.1 million in expenditures.
Future Objectives and Next Steps
The current segment of the program is set to conclude within six months from the start date. Following that, the company plans to initiate an additional €500 million buyback. This subsequent phase is contingent on the successful sale of dsm-firmenich’s assets in the Feed Enzymes Alliance, a transaction that has recently received attention.
Commitment to Shareholders
By committing to such substantial share repurchase amounts, dsm-firmenich reiterates its dedication to returning value to its shareholders. This proactive approach toward capital management reflects the company's ongoing focus on robust financial health while striving to enhance its market position amid evolving industry challenges.
About dsm-firmenich
dsm-firmenich is dedicated to improving lives through its innovative solutions in nutrition, health, and beauty. The company specializes in creating essential nutrients, flavors, and fragrances, utilizing leading-edge science and a commitment to sustainability. With a diverse workforce spanning nearly 30,000 employees in almost 60 countries, dsm-firmenich achieves revenues exceeding €12 billion, constantly innovating to meet global demand.
Contact Information
For further inquiries, dsm-firmenich welcomes communications directed to:
Investor Relations:
Email: investors@dsm-firmenich.com
Media Enquiries:
Email: media@dsm-firmenich.com
Frequently Asked Questions
What is the primary purpose of the share repurchase program?
The program aims to enhance shareholder value by repurchasing shares to reduce the number of outstanding shares and manage capital effectively.
How much has dsm-firmenich committed to the share buyback?
dsm-firmenich has committed to repurchasing €1 billion worth of shares in total, starting with an initial €500 million allocation.
What is the average price paid for shares repurchased?
The average buyback price to date is €94.84 per share, with €300.1 million utilized toward this effort.
When is the current share repurchase program expected to conclude?
The current program is set to complete by the end of the six-month period from its commencement on April 1, 2025.
How does dsm-firmenich ensure sustainable practices?
dsm-firmenich is committed to sustainability, focusing on using natural and renewable ingredients while driving innovation in its product offerings to benefit the planet.
